Provided by Tiger Fintech (Singapore) Pte. Ltd.

Regulus Therapeutics

3.49
+0.730026.45%
Pre-market: 3.500.0100+0.29%09:07 EDT
Volume:4.77M
Turnover:16.13M
Market Cap:231.19M
PE:-4.24
High:3.73
Open:2.78
Low:2.76
Close:2.76
Loading ...
Mar 22, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Mar 21, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 21, 2024

Major Issues Report

Form 8-K - Current report
Mar 20, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Mar 18, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Mar 14, 2024

Major Issues Report

Form 8-K - Current report
Feb 06, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 18, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 12, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jan 06, 2024

Correspondence

Form CORRESP - Correspondence
Nov 10, 2023

Major Issues Report

Form 8-K - Current report
Nov 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2023

Major Issues Report

Form 8-K - Current report
Jun 29, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 23, 2023

Major Issues Report

Form 8-K - Current report
Jun 14, 2023

Major Issues Report

Form 8-K - Current report
Jun 12, 2023

Major Issues Report

Form 8-K - Current report
May 17, 2023

Correspondence

Form CORRESP - Correspondence
May 12, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership